| Trial ID: | L0176 |
| Source ID: | NCT00590161
|
| Associated Drug: |
Pentoxifylline
|
| Title: |
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT00590161/results
|
| Conditions: |
Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: pentoxifylline (PTX)|Drug: placebo
|
| Outcome Measures: |
Histological Improvement of at Least 2 Points in NAFLD Activity Score (NAS) on Liver Biopsy After One Year.
|
| Sponsor/Collaborators: |
Case Western Reserve University|American College of Gastroenterology
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
55
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
December 2006
|
| Completion Date: |
December 2010
|
| Results First Posted: |
September 26, 2013
|
| Last Update Posted: |
September 26, 2013
|
| Locations: |
Louis Stokes VA Medical Center, Cleveland, Ohio, United States|Metrohealth Medical Center, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00590161
|
